Researchers conducted a post hoc analysis of a multicenter study in 13 intensive care units in Europe. They used prospective surveillance data and a mathematical model to estimate transmission capacities and single-admission reproduction numbers of Escherichia coli and non-E. coli Enterobacteriaceae — all resistant to expanded-spectrum cephalosporins.
The study shows of 11,420 patients included in the analysis the admission prevalence was 3.8 percent for non-E. coli Enterobacteriaceae, or non-EcE, and 3.3 percent for E. coli. Around 74 percent of non-EcE admissions were for Klebsiella pneumoniae. The acquisition rates were 7.4 and 2.6 per 100 admissions at risk for non-EcE and E. coli, respectively.
The estimated transmission capacity of non-EcE was 3.7 times higher than that of E. coli, resulting in single-admission reproduction numbers of 0.17 for non-EcE and 0.047 for E. coli.
More articles on healthcare quality:
Risk assessment scale accurately predicts pressure injuries in pediatric patients, study finds
Hygiene tripods, algorithms and more: How St. Louis University Hospital is battling flu season
86 infected with norovirus at 2018 Olympic Winter Games
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
